
Drug R&D Public Funding – The Next Level Of Price Transparency Policies?
French lawmakers are setting the scene for a showdown with manufacturers defending their drug prices with R&D investment figures.
French lawmakers are setting the scene for a showdown with manufacturers defending their drug prices with R&D investment figures.
France’s healthcare industry strategic council CSIS met an agreement with the French Government to strengthen France’s appeal for HealthCare industries. Inbeeo dives in to investigate the impact on market access and pricing.